A global pharmaceutical company with cutting-edge capabilities in drug development and a history of successful academic collaborations wishes to identify infectious disease therapeutics and vaccines in European institutes, targeting Hepatitis B and Hepatitis D virus infection.
Further information
Our client wishes to identify technologies, research projects and spin‑out companies at any stage of development, from basic research to Phase I, focusing on the treatment of Hepatitis B and/or Hepatitis D. Vaccines, novel therapeutics and selective targeting ...